Sunday, 24 January 2021
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
JHOP Print Edition
We will request your mailing address on the next page.
JHOP E-Newsletters & Communications
TOP Print Edition
We will request your mailing address on the next page.
TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
JHOP
's
Privacy Policy
, and
JHOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date
Home
Issues
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
2019
December 2019 Vol 9, No 4
September 2019 Vol 9, No 3
June 2019 Vol 9, No 2
March 2019 Vol 9, No 1
2018
December 2018 Vol 8, No 4
September 2018 Vol 8, No 3
June 2018 Vol 8, No 2
March 2018 Vol 8, No 1
2017
December 2017 Vol 7, No 4
September 2017 Vol 7, No 3
June 2017 Vol 7, No 2
March 2017 Vol 7, No 1
Issue Archive
Special Issues
Supplements
2020 Year in Review - Breast Cancer
2020 Year in Review - Biosimilars
2020 Year in Review - Acute Myeloid Leukemia
2020 Year in Review - Cholangiocarcinoma
2020 Year in Review - Lung Cancer
2020 Year in Review - Neuroendocrine Tumors
2020 Year In Review - Ovarian Cancer
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2020 - Lung Cancer
ASH 2020 - Multiple Myeloma
ESMO 2020 Highlights
SABCS 2020 Highlights
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals
In the News
Online First
Press Releases
Media Library
Videos
Audiocasts
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview Guidelines
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
About GreenhillHC
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
Patricia Stewart
Authored Items
Explosion of New Regimens for Multiple Myeloma: Selecting the Right Option for the Right Patient
Patricia Stewart
TON - December 2020, Vol 13, No 6
in
NCCN
Aggressive Approach to High-Risk Smoldering Myeloma Gains Consensus
Patricia Stewart
TON - December 2020, Vol 13, No 6
in
NCCN
CAR T-Cell Therapy May Not Be Needed for Select Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Patricia Stewart
TON - December 2020, Vol 13, No 6
in
NCCN
Sotorasib Demonstrates Promising Antitumor Activity in Patients with Advanced NSCLC
Patricia Stewart
TON - December 2020, Vol 13, No 6
in
Emerging Therapies
Xevinapant plus CRT Improves Survival in Patients with Locally Advanced HNSCC
Patricia Stewart
TON - December 2020, Vol 13, No 6
in
Emerging Therapies
Personalized Vaccine plus Atezolizumab Shows Promising Clinical Activity in Advanced Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
AACR Highlights
Olaparib Significantly Improves Survival in Men with Metastatic Prostate Cancer and BRCA Mutations
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
ESMO 2020
“Practice-Changing” Results Seen with Adjuvant Abemaciclib plus Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
ESMO 2020
Cabozantinib plus Nivolumab Offers New First-Line Treatment Option for Patients with Advanced Renal-Cell Carcinoma
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
ESMO 2020
Real-World Analysis Shows Survival Benefit with Adjuvant Immunotherapy in Stage III Melanoma
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
AACR Highlights
COVID-19: Facing the Challenges Ahead
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
AACR Highlights
,
COVID-19
COVID-19 Increases Overall Risk for Death in Patients with Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
AACR Highlights
,
COVID-19
Immune Checkpoint Inhibitors Do Not Increase Mortality in Patients with Cancer and COVID-19
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
AACR Highlights
,
COVID-19
Relugolix May Become New Standard of Care for Advanced Prostate Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
Prostate Cancer
Surgery and Radiation Do Not Extend Survival in Newly Diagnosed Stage IV Breast Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6
in
Breast Cancer
Last modified: August 17, 2020
Home
Issues
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
2019
December 2019 Vol 9, No 4
September 2019 Vol 9, No 3
June 2019 Vol 9, No 2
March 2019 Vol 9, No 1
2018
December 2018 Vol 8, No 4
September 2018 Vol 8, No 3
June 2018 Vol 8, No 2
March 2018 Vol 8, No 1
2017
December 2017 Vol 7, No 4
September 2017 Vol 7, No 3
June 2017 Vol 7, No 2
March 2017 Vol 7, No 1
Issue Archive
Special Issues
Supplements
2020 Year in Review - Breast Cancer
2020 Year in Review - Biosimilars
2020 Year in Review - Acute Myeloid Leukemia
2020 Year in Review - Cholangiocarcinoma
2020 Year in Review - Lung Cancer
2020 Year in Review - Neuroendocrine Tumors
2020 Year In Review - Ovarian Cancer
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2020 - Lung Cancer
ASH 2020 - Multiple Myeloma
ESMO 2020 Highlights
SABCS 2020 Highlights
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals
In the News
Online First
Press Releases
Media Library
Videos
Audiocasts
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview Guidelines
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
About GreenhillHC
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
